RxDoctor Payments Data

Stacey Jantsch

Family · Syracuse, NYNPI 1861091324

Payments from drug & device makers

$750in general payments, 2019–2025

Across 43 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$287
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$157
  • Takeda Pharmaceuticals U.S.A., Inc.$90
  • Nestle Healthcare Nutrition Inc.$59
  • QOL Medical, LLC$54
  • Braintree Laboratories, Inc.$24
  • plus $80 from 5 others

What the payments were for

  • Food & beverage$750100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$750 in reported general payments places this provider in the 65th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$46,416
Medicare patients
136
Services billed
685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate14$57

Paid to pharmacies, not to this prescriber.

Other family in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →